Abstract
Lipid altering pharmacotherapy has been shown to reduce stroke in coronary heart disease (CHD) patients. Several mechanisms of cerebrovascular protection attributed to these agents include reduction in embolic stroke from cardiac, aortic and carotid sites, delayed progression of carotid stenoses, stabilization of vulnerable carotid atherosclerotic plaque and improvement in cerebral blood flow.
| Original language | English |
|---|---|
| Pages (from-to) | 731-738 |
| Number of pages | 8 |
| Journal | Drugs of Today |
| Volume | 37 |
| Issue number | 11 |
| DOIs | |
| State | Published - 2001 |
| Externally published | Yes |